Updated:
Pappas Ventures
Pappas Ventures is a venture capital firm investing in early-stage life sciences and healthcare companies, with a focus on therapeutics and medical...
Pappas Ventures
Pappas Ventures is a venture capital firm that targets early-stage life sciences and healthcare companies. The firm was founded by a team with experience in the healthcare sector. Its investment strategy centers on backing companies developing innovative therapies, medical devices, and diagnostic tools. The firm typically leads or co-leads Series A and Series B rounds, providing capital alongside operational support. Its portfolio includes companies such as (example) and (example), though specific holdings are not publicly disclosed in detail. Geographic focus is primarily North America, with a preference for US-based opportunities. Pappas Ventures has raised multiple funds over its history, with capital from institutional investors and family offices. The team size and number of investment professionals are not publicly specified. Recent activity includes continued deployment into early-stage healthcare companies, but exact dates and deal sizes are not available. The firm differentiates itself through its deep sector expertise in healthcare and life sciences, enabling it to source and evaluate complex scientific opportunities. Its network within the industry provides access to proprietary deal flow and co-investment relationships.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
—
City
—
Corporate office
—
Sector focus
Frequently asked questions
What investment stages does Pappas Ventures typically target?
Pappas Ventures focuses on early-stage investments, particularly Series A and Series B rounds in life sciences and healthcare companies. The firm seeks to lead or co-lead rounds where it can provide strategic guidance alongside capital.
Which sectors does Pappas Ventures invest in?
The firm targets healthcare and life sciences, including therapeutics, medical devices, and diagnostics. It avoids non-healthcare sectors, concentrating exclusively on science-driven opportunities.
Does Pappas Ventures invest globally or only in specific regions?
Pappas Ventures primarily invests in North America, with a focus on the United States. The firm's portfolio concentrates on US-based companies, leveraging local regulatory and market expertise.
How does Pappas Ventures source its deal flow?
The firm sources deals through its network of industry contacts, including scientific advisors, entrepreneurs, and other venture capitalists. Its specialization in healthcare allows it to identify emerging opportunities in therapeutics and devices.
What is the firm's investment philosophy regarding risk?
Pappas Ventures invests in early-stage companies with significant upside potential but accepts the associated high risk. The firm diversifies across multiple portfolio companies to mitigate individual setbacks, typical of venture capital strategy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: